This paper is in the following e-collection/theme issue:

Clinical Information and Decision Making (1573) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (175) Drug Repurposing and Off-Label Use (27) Digital Health Reporting Standards, Quality and Transparency in e-Research (92)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65872, first published .
Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Authors of this article:

Huanhuan Ji1 Author Orcid Image ;   Meiling Gong1, 2 Author Orcid Image ;   Li Gong3 Author Orcid Image ;   Ni Zhang4 Author Orcid Image ;   Ruiou Zhou1 Author Orcid Image ;   Dongmei Deng1 Author Orcid Image ;   Ya Yang1 Author Orcid Image ;   Lin Song1 Author Orcid Image ;   Yuntao Jia1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Huanhuan Ji   1 , MS ;   Meiling Gong   1, 2 , MS ;   Li Gong   3 , MS ;   Ni Zhang   4 , MS ;   Ruiou Zhou   1 , BS ;   Dongmei Deng   1 , MS ;   Ya Yang   1 , MS ;   Lin Song   1 * , PhD ;   Yuntao Jia   1 * , MS

1 Department of Pharmacy, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical University, Chongqing, China

2 School of Pharmacy, Chongqing Medical University, Chongqing, China

3 Department of Phase I Clinical Trial Ward, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China

4 Department of Pharmacy, The Daping Hospital of Army Medical University, Chongqing, China

*these authors contributed equally

Corresponding Author:

  • Yuntao Jia, MS
  • Department of Pharmacy
  • National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders
  • Children’s Hospital of Chongqing Medical University
  • No. 136, Zhongshan 2nd Road
  • Yuzhong District
  • Chongqing, 400014
  • China
  • Phone: 86 13883533546
  • Email: jiayuntaomail@hospital.cqmu.edu.cn